66852-54-8
- Product Name：Halobetasol propionate
- Molecular Formula：C25H31ClF2O5
- Purity：99%
- Molecular Weight：484.968
Product Details;
CasNo： 66852-54-8
Molecular Formula： C25H31ClF2O5
Appearance： Distributed as 0.05% ointment.
Factory Sells Best Quality Halobetasol propionate 66852-54-8 with ISO standards
- Molecular Formula:C25H31ClF2O5
- Molecular Weight:484.968
- Appearance/Colour:Distributed as 0.05% ointment.
- Vapor Pressure:0mmHg at 25°C
- Melting Point:-32°C
- Refractive Index:1.551
- Boiling Point:570.7 °C at 760 mmHg
- PKA:12.55±0.70(Predicted)
- Flash Point:298.9 °C
- PSA：80.67000
- Density:1.31 g/cm3
- LogP:4.05110
Halobetasol propionate(Cas 66852-54-8) Usage
|
Brand name |
Ultravate (Westwood-Squibb). |
InChI:InChI=1/C25H31ClF2O5/c1-5-33-21(32)24(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)25(16,28)19(30)11-23(15,24)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24+,25-/m0/s1
66852-54-8 Relevant articles
A PROCESS FOR PREPARING A CRYSTALLINE FORM OF HALOBETASOL PROPIONATE
-
Page/Page column 25, (2008/06/13)
The present invention provides a process...
Crystalline forms of halobetasol propionate
-
Page 6, (2008/06/13)
The present invention provides a crystal...
Method for the preparation of 6alpha-fluoro corticosteroids
-
, (2008/06/13)
A method for producing a 6α-fluorinated ...
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
-
, (2008/06/13)
Methods for reducing or preventing trans...
66852-54-8 Process route
-
-
84509-92-2
6α,9α-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione, 17-propionate 21-mesylate
-
-
66852-54-8
halobetasol propionate
-
-
98651-66-2
halobetasol
-
![6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3-(2'H)-one]](/upload/2026/9/6f2f1b80-d01b-47fb-8804-93f1a32a27c9.png)
-
6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3-(2'H)-one]
-
-
541502-98-1
6α,9α-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione, 21-propionate
-
-
924726-89-6
6α,9α-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione, 17-propionate
-
-
2557-49-5
11β,17α,21-trihydroxy-6α,9α-difluoro-16β-methylpregna-1,4-diene-3,20-dione
| Conditions | Yield |
|---|---|
|
6α,9α-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione, 17-propionate 21-mesylate;
With
lithium chloride;
In
ISOPROPYLAMIDE;
at 80 ℃;
for 3h;
With
water;
In
ISOPROPYLAMIDE;
at 20 ℃;
for 1.83333h;
|
-
-
halobetasol propionate methylene chloride
-
-
66852-54-8
halobetasol propionate
| Conditions | Yield |
|---|---|
|
at 140 ℃;
for 0.166667h;
|
66852-54-8 Upstream products
-
84509-92-2
6α,9α-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione, 17-propionate 21-mesylate
Relevant Products
-
Nilotinib HClCAS：923288-90-8
-
DocetaxelCAS：114977-28-5
-
1,5-Hexadiene-3,4-diolCAS：1069-23-4
